Can Fite Biofarma: Q1 Earnings Insights

Can Fite Biofarma CANF reported its Q1 earnings results on Thursday, May 26, 2022.

Here's what investors need to know about the announcement.

Can Fite Biofarma missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.14.

Revenue was up $57.00 thousand from the same period last year.

Last quarter the company beat on EPS by $0.17 which was followed by a 4.35% increase in the share price the next day.

Here's a look at Can Fite Biofarma's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.18	-0.09	-0.10	-0.16
EPS Actual	-0.01	-0.20	-0.01	0
Revenue Estimate	250.00K	150.00K	120.00K	200.00K
Revenue Actual	204.00K	251.00K	250.00K	148.00K

To track all earnings releases for Can Fite Biofarma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.